It's Time to Build in Healthcare: COVID-19, Innovation, and What Comes Next

In this episode of Bio Eats World, a16z founder and internet pioneer Marc Andreessen and general partner Jorge Conde zoom out to discuss the large scale societal effects of the current pandemic on society, healthcare, biotech, and innovation. COVID-19 has been catastrophic—but also catalyzed enormous change and a dramatic groundswell of innovation. Where are we now? Which of these changes will stay, and which may recede? What new innovations and impacts might be still to come, and what are we learning that can be applied towards the future?

Building on Marc Andreessen's article and call to action, “It’s Time to Build,” Jorge and Marc discuss what needs to be built in healthcare today (for example, would a pandemic warning system help us next time?); the impact of COVID-19 on innovation and mindsets in the biopharma industry; the shift towards measuring output that could spur more innovation; and finally, what biopharma and venture capital have in common in terms of risk and experimentation that might serve as a much broader model.